Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.37 Analyst target: $2.00 Upside: 434.76%
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.